NFL Biosciences SA
Paris Stock Exchange ALNFL.PA
NFL Biosciences SA Total Assets for the year ending December 31, 2023: USD 4.38 M
NFL Biosciences SA Total Assets is USD 4.38 M for the year ending December 31, 2023. Total assets are the total value of all assets owned by a company, representing its resources.
-
NFL Biosciences SA Total Assets for the year ending December 31, 2021 was USD 4.20 M.
Key data
| Date | Total Assets | Current Liabilities | Total Non-Current Liabilities | Shareholders' Equity |
|---|
Market news
Loading...
Paris Stock Exchange: ALNFL.PA
| CEO | Dr. Ignacio Faus M.B.A., Ph.D. |
| IPO Date | July 5, 2021 |
| Location | France |
| Headquarters | 199 Rue Helene Boucher |
| Employees | 4 |
| Sector | Health Care |
| Industries | |
Description
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
Key trends
Past 5 years
Similar companies
ABIONYX Pharma SA
USD 1.29
-1.75%
StockViz Staff
January 15, 2025
Any question? Send us an email